Advertisement

Gynecological Issues in Girls and Young Women with Cerebral Palsy

  • Beth I. Schwartz
  • Chelsea Kebodeaux
Living reference work entry

Abstract

Girls and young women with cerebral palsy face more difficulties than their nondisabled peers. In particular, reproductive health issues can be more complicated for adolescents with disabilities. This can be an area of significant apprehension and frustration for young women and their families. Medical providers often have limited training and comfort caring for young women with disabilities, especially with gynecologic issues in this population. As a result, adolescents with disabilities, and with cerebral palsy in particular, are less likely to receive education about reproductive health. In addition, confidentiality, a key tenet of adolescent health care, is often overlooked in this population. This chapter aims to provide education about reproductive health for young women with cerebral palsy, with a focus on menstrual management and contraceptive options.

Keywords

Cerebral palsy Gynecology Reproductive health Menstrual suppression Contraception 

References

  1. American College of Obstetricians and Gynecologists (2005) Access to reproductive health care for women with disabilities. In: Special issues in women’s health: special populations. Available via: https://www.acog.org/Resources-And-Publications/Special-Issues-in-Womens-Health. Accessed 14 Aug 2017
  2. American College of Obstetricians and Gynecologists (2012) Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol 120:983–988CrossRefGoogle Scholar
  3. American College of Obstetricians and Gynecologists (2014a) Committee opinion no. 598: the initial reproductive health visit. Obstet Gynecol 123:1143–1147CrossRefGoogle Scholar
  4. American College of Obstetricians and Gynecologists (2014b) Guidelines for women’s health care: a resource manual, 4th edn. Available via: https://www.acog.org/Resources-And-Publications/Guidelines-for-Womens-Health-Care. Accessed 14 Aug 2017
  5. American College of Obstetricians and Gynecologists (2015) Committee opinion no. 651: menstruation in girls and adolescents using the menstrual cycle as a vital sign. Obstet Gynecol 126:e143–e146CrossRefGoogle Scholar
  6. American College of Obstetricians and Gynecologists (2016) Committee opinion no. 668: menstrual manipulation for adolescents with physical and developmental disabilities. Obstet Gynecol 128:e20–e25CrossRefGoogle Scholar
  7. Darney P, Patel A, Rosen K et al (2009) Safety and efficacy of a single-rod etonorgestrel implant (Implanon): results from 11 international clinical trials. Fertil Steril 91:1646–1653CrossRefGoogle Scholar
  8. East LJ, Orchard TR (2014) Somebody else’s job: experiences of sex education among health professionals, parents and adolescents with physical disabilities in southwestern Ontario. Sex Disabil 32:335–350CrossRefGoogle Scholar
  9. Foldvary-Schaefer N, Harden C, Herzog A et al (2004) Hormones and seizures. Cleve Clin J Med 71:S11–S18CrossRefGoogle Scholar
  10. Herzog AG, Schachter SC (2001) Valproate and the polycystic ovarian syndrome: final thoughts. Epilepsia 42:311–315CrossRefGoogle Scholar
  11. Hidalgo M, Bahamondes L, Perrotti M et al (2002) Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception 65:129–132CrossRefGoogle Scholar
  12. Kaser DJ, Missmer SA, Berry KF et al (2012) Use of norethindrone acetate alone for postoperative suppression of endometriosis symptoms. J Pedatr Adolesc Gynecol 25:105–108CrossRefGoogle Scholar
  13. Kirkham YA, Allen L, Kives S et al (2013) Trends in menstrual concerns and suppression in adolescents with developmental disabilities. J Adolesc Health 53:407–412CrossRefGoogle Scholar
  14. Lindoff C, Rybo G, Astedt B (1993) Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications. Thromb Haemost 70:238–240PubMedGoogle Scholar
  15. Lohiya GS, Tan-Figueroa L, Silverman S et al (2006) The wheelchair thrombosis syndrome. J Natl Med Assoc 98:1188–1192PubMedPubMedCentralGoogle Scholar
  16. Mitra M, Mouradian VE, McKenna M (2013) Dating violence and associated health risks among high school students with disabilities. Matern Child Health J 17:1088–1094CrossRefGoogle Scholar
  17. Mitra M, Clements KM, Zhang J et al (2016) Disparities in adverse preconception risk factors between women with and without disabilities. Matern Child Health J 20:507–515CrossRefGoogle Scholar
  18. Oeffinger KC, Fontham ETH, Etzioni R et al (2015) Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA 314:1599–1614CrossRefGoogle Scholar
  19. Pfizer. Depo-Provera CI U.S. physician prescribing information. Available via: http://labeling.pfizer.com/ShowLabeling.aspx?id=522. Accessed 25 Sept 2017
  20. Pillai M, O’Brien K, Hill E (2010) The levonorgestrel IUS (Mirena) for the treatment of menstrual problems in adolescents with medical disorders or physical or learning disabilities. BJOG 117:216–221CrossRefGoogle Scholar
  21. Poulos AE, Balandin S, Llewellyn G et al (2006) Women with cerebral palsy and breast cancer screening by mammography. Arch Phys Med Rehabil 87:304–307CrossRefGoogle Scholar
  22. Quint EH (2014) Menstrual and reproductive issues in adolescents with physical and developmental disabilities. Obstet Gynecol 124:367–375CrossRefGoogle Scholar
  23. Quint EH, Elkins TE, Sorg CA et al (1999) The treatment of cyclical behavioral changes in women with mental disabilities. J Pediatr Adolesc Gynecol 12:139–142CrossRefGoogle Scholar
  24. Savasi I, Jayasinghe K, Moore P et al (2014) Complication rates associated with levonorgestrel intrauterine system use in adolescents with developmental disabilities. J Pediatr Adolesc Gynecol 27:25–28CrossRefGoogle Scholar
  25. Scholes D, LaCroix AZ, Ichikawa LE et al (2005) Change in bone mineral density among adolescent women discontinuing depot medroxyprogesterone acetate contraception. Arch Pediatr Adolesc Med 159:139–144CrossRefGoogle Scholar
  26. Schreiber CA, Barnhart K (2014) Contraception. In: Strauss JF, Barbieri RL (eds) Yen & Jaffe’s Reproductive endocrinology, 7th edn. Elsevier Saunders, PhiladelphiaGoogle Scholar
  27. Sellwood D, Raghavendra P, Jewell P (2017) Sexuality and intimacy for people with congenital physical and communication disabilities: barriers and facilitators: a systematic review. Sex Disabil 35:227–244CrossRefGoogle Scholar
  28. Signore C, Spong CY, Krotoski D (2011) Pregnancy in women with physical disabilities. Obstet Gynecol 117:935–947CrossRefGoogle Scholar
  29. Thierry JM (2006) The importance of preconception care for women with disabilities. Matern Child Health J 10:S195–S196CrossRefGoogle Scholar
  30. Wiegerink D, Roebroeck M, Bender J et al (2011) Sexuality of young adults with cerebral palsy: experienced limitations and needs. Sex Disabil 29:119–128CrossRefGoogle Scholar
  31. Worley G, Houlihan CM, Herman-Giddens ME et al (2002) Secondary sexual characteristics in children with cerebral palsy and moderate to severe motor impairment: a cross-sectional survey. Pediatrics 110:897–902CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Obstetrics & GynecologyThomas Jefferson UniversityPhiladelphiaUSA
  2. 2.Division of Adolescent Medicine and Pediatric Gynecology, Department of PediatricsNemours/A.I. duPont Hospital for ChildrenWilmingtonUSA
  3. 3.Department of Obstetrics & GynecologyChristiana Care Health SystemNewarkUSA

Section editors and affiliations

  • Freeman Miller
    • 1
  • Steven Bachrach
    • 2
  1. 1.AI DuPont Hospital for ChildrenWilmingtonUSA
  2. 2.Al duPont Hospital for ChildrenWilmingtonUSA

Personalised recommendations